W Yu, C Chen, C Xu, D Xie, Q Wang,
W Liu… - The American Journal …, 2022 - World Scientific
Doxorubicin (DOX) is a most common anthracycline chemotherapeutic agent; however, its
clinical efficacy is limited due to its severe and irreversible cardiotoxicity. Ferroptosis …